The University of Southampton
University of Southampton Institutional Repository

Haplotypic analyses of the IGF2-INS-TH gene cluster in relation to cardiovascular risk traits

Haplotypic analyses of the IGF2-INS-TH gene cluster in relation to cardiovascular risk traits
Haplotypic analyses of the IGF2-INS-TH gene cluster in relation to cardiovascular risk traits
The IGF2–INS–TH genomic region has been implicated in various common disorders including the metabolic syndrome, type 2 diabetes and coronary heart disease (CHD). Here we present detailed haplotype analysis of 2743 males 51–62 years old in relation to body weight and composition, blood pressure (BP) and plasma triglycerides (TG). Use of the total data set was complicated by the number of loci typed, missing data, multi-allelic markers and continuous trait phenotypes. Different algorithms and subsets of the data were analysed using the programmes haplotype trend regression, haplo.score, evolutionary-based haplotype analysis package and Phase, in conjunction with SPSS. Ten haplotypes designated in frequency order *1(20.0%) to *10(3.4%) represented 89% of all haplotypes. Haplotype *5 protected against obesity. Haplotype *4 carriers exhibited elevated BP and fat mass, haplotype *6 was associated with raised plasma TG levels. Haplotype *8 also showed similar magnitude effects as *4. These cohort trait analyses and detailed haplotypic analyses enable integration with published case data. Haplotypes *4, *6 and *8 are the only INS VNTR class III-bearing haplotypes, although differing in flanking haplotype, whereas *5 displays unique features in all three genes (with significant commonality with type 1 diabetes-predisposition haplotypes). We propose that long repeat insertion in the insulin gene promoter (‘class III’), reported to result in low insulin production, predisposes to the metabolic syndrome features of elevated BP, fat mass or TG level, therefore appearing more frequently in type 2 diabetic, polycystic ovary syndrome and CHD cases. The functional element(s) of *5 for weight-lowering could reside in any of the three genes.
715 - 725
Rodriguez, S.
b047a823-28c8-4043-8d4f-dc6b23f52e4e
Gaunt, T.R.
0867a942-06a8-4e40-9c97-c47124d474e9
O'Dell, S.D.
7879476b-b069-4cd8-9917-33debec87860
Chen, X.H.
fe7ddffb-99db-4473-8d70-c9ecc07f2b16
Gu, D.
a326e3fc-9ec4-474d-843b-f148d4e45924
Hawe, E.
04b00658-cb75-42fc-9213-9c3ba8372105
Miller, G.J.
c0be8252-47b0-4482-a977-25ac06cf59df
Humphries, S.E.
ccc89458-fe7c-4cce-92a3-470dac1b33b6
Day, I.N.
e9cacaf7-f4c8-4ef0-82fa-b459ad683d50
Rodriguez, S.
b047a823-28c8-4043-8d4f-dc6b23f52e4e
Gaunt, T.R.
0867a942-06a8-4e40-9c97-c47124d474e9
O'Dell, S.D.
7879476b-b069-4cd8-9917-33debec87860
Chen, X.H.
fe7ddffb-99db-4473-8d70-c9ecc07f2b16
Gu, D.
a326e3fc-9ec4-474d-843b-f148d4e45924
Hawe, E.
04b00658-cb75-42fc-9213-9c3ba8372105
Miller, G.J.
c0be8252-47b0-4482-a977-25ac06cf59df
Humphries, S.E.
ccc89458-fe7c-4cce-92a3-470dac1b33b6
Day, I.N.
e9cacaf7-f4c8-4ef0-82fa-b459ad683d50

Rodriguez, S., Gaunt, T.R., O'Dell, S.D., Chen, X.H., Gu, D., Hawe, E., Miller, G.J., Humphries, S.E. and Day, I.N. (2004) Haplotypic analyses of the IGF2-INS-TH gene cluster in relation to cardiovascular risk traits. Human Molecular Genetics, 13 (7), 715 - 725. (doi:10.1093/hmg/ddh070).

Record type: Article

Abstract

The IGF2–INS–TH genomic region has been implicated in various common disorders including the metabolic syndrome, type 2 diabetes and coronary heart disease (CHD). Here we present detailed haplotype analysis of 2743 males 51–62 years old in relation to body weight and composition, blood pressure (BP) and plasma triglycerides (TG). Use of the total data set was complicated by the number of loci typed, missing data, multi-allelic markers and continuous trait phenotypes. Different algorithms and subsets of the data were analysed using the programmes haplotype trend regression, haplo.score, evolutionary-based haplotype analysis package and Phase, in conjunction with SPSS. Ten haplotypes designated in frequency order *1(20.0%) to *10(3.4%) represented 89% of all haplotypes. Haplotype *5 protected against obesity. Haplotype *4 carriers exhibited elevated BP and fat mass, haplotype *6 was associated with raised plasma TG levels. Haplotype *8 also showed similar magnitude effects as *4. These cohort trait analyses and detailed haplotypic analyses enable integration with published case data. Haplotypes *4, *6 and *8 are the only INS VNTR class III-bearing haplotypes, although differing in flanking haplotype, whereas *5 displays unique features in all three genes (with significant commonality with type 1 diabetes-predisposition haplotypes). We propose that long repeat insertion in the insulin gene promoter (‘class III’), reported to result in low insulin production, predisposes to the metabolic syndrome features of elevated BP, fat mass or TG level, therefore appearing more frequently in type 2 diabetic, polycystic ovary syndrome and CHD cases. The functional element(s) of *5 for weight-lowering could reside in any of the three genes.

This record has no associated files available for download.

More information

Published date: 2004

Identifiers

Local EPrints ID: 24926
URI: http://eprints.soton.ac.uk/id/eprint/24926
PURE UUID: a2a9822e-d73e-4886-b82b-75ba4b7bbbb8

Catalogue record

Date deposited: 04 Apr 2006
Last modified: 15 Mar 2024 06:59

Export record

Altmetrics

Contributors

Author: S. Rodriguez
Author: T.R. Gaunt
Author: S.D. O'Dell
Author: X.H. Chen
Author: D. Gu
Author: E. Hawe
Author: G.J. Miller
Author: S.E. Humphries
Author: I.N. Day

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×